hip fractures in the royal victoria hospital, belfast: a ... · hip fractures in the royal victoria...

1
Hip fractures in the Royal Victoria Hospital, Belfast: A 15-year experience for hip fractures from a regional trauma centre Mrs Julie Craig (Orthopaedic Specialty Doctor), Mrs Sinead McDonald (Fracture Outcomes Research Database), Dr Gary Heyburn (Consultant Ortho-physician), Mr R John Barr (Consultant Orthopaedic Surgeon) Royal Victoria Hospital, Belfast Background The Royal Victoria Hospital (RVH) in Belfast received 865 – 1066 hip fracture admission per year in from 2000-2015 The Fracture Outcomes Research Database (FORD) was created 16 years ago for collection of inpatient fracture data. Low 30-Day mortality rate The UK National Hip Fracture Database (NHFD) identified RVH as the sole ”‘outlier’ – with mortality below the lower 99.8% limit” [1] for hip fracture admissions in 2014 (Figure 1). ‘In 2014 the crude mortality rate (4.4%) & adjusted rate (3.9%) for this unit lay well below the 7.5% average for the NHFD.’ [1] Mortality rates have been independently verified by Business Services Organisation. Aim The aim was to review demographic and clinical factors which may have contributed to these low mortality rates and their gradual improvement over several years. Results Improvements not attributable to lower ASA or ASA grades: Increasing mean patient age (now 60% aged 80 or over – Figure 2). Increasing mean ASA (now 54% ASA Grade 3 and 26% ASA 4 – Figure 3). Improvements not attributable to ‘easier operations’: Increasing numbers of more complex procedures such as IM nails and THR (Figure 4). Improved compliance with evidence-based guidance has occurred (e.g. NICE guidelines [2] and AAGBI guidelines [3] ) Cemented hemiarthoplasty is used in almost 75% of displaced intracapsular fractures (Figure 5). The rate of THR for eligible patients (25%) has been close to the NHFD average. All arthroplasty is cemented, with routine use of the AAGBI guidelines on reducing the risk from cemented hemiarthroplasty [3] . Over 75% of ‘simple’ extracapsular fractures are treated with a DHS, & the rest with IM nails (Figure 6). IM nails are now used for 94% of subtrochanteric fractures (Figure 7) . Good adherence to other points of NICE guidance has been routinely implemented (Figure 8). Time to theatre remains an issue, with most patients waiting around two days for surgery, of which over 80% is RVH inpatient waiting time (Figure 9). RVH is subject to UK Department of Health 48-hour targets. The Best Practice Tariff funding criteria (not available in Northern Ireland) require surgery to occur on the day of admission or the following day. Considering 36 hours as more comparable this, only 26% of RVH patients were operated on within 36 hours in 2014 (Figure 10). Mortality rates for the first 30 days, and for 1 year, are low and have been gradually improving (Figure 11). The highest mortality rate occurs in the very small number of patients (<2%) who cannot be medically optimised to allow surgery (shown in orange in Figure 12 ). However, mortality rates have been low for operated patients of all ASA grades. 30-day mortality rates rise with ASA, but recent results have been improved in comparison with the average since 2000 (stated as ‘overall’ in Figure 13). While we are striving to improve waiting times and don’t for a moment condone delays, we have observed that patients who had to wait over 36 hours had a better 30-day survival rate than those operated on within 36 hours ( Figure 14 ). This is difficult to explain but it is probably due to our high level of ortho -physician care (Figure 15). It is our view that our key strength is our multidiscliplinary team work in the best interests of each patient. Conclusion RVH displays low 30-day mortality rates despite delays to theatre, seemingly due to: Rationalisation of treatment according to evidence and guidelines High level of ortho-physician input and, Multi-disciplinary co-operation. With special thanks to the staff of the Fracture Outcomes Research Database (FORD), Mr J Elliott & Dr T Beringer [1] Royal College of Physicians. National Hip Fracture Database mortality supplement 2016. London: RCP, 2016. [2] National Clinical Guideline Centre. The Management of Hip Fracture in Adults. London: National Clinical Guideline Centre, 2011. www.nice.org.uk/guidance/cg124 [3] Association of Anaesthetists of Great Britain and Ireland. Safety guideline: reducing the risk from cemented hemiarthroplasty for hip fracture 2015. Anaesthesia 2015, 70, 623–626. Method The Fracture Outcomes Research Database supplied data for 15,345 hip fracture patients admitted to RVH between 2000 & 2015, including inpatient data and telephone follow- up data (for 30 days, 120 days, and 1 year excluding patients in 2015). No age-groups were excluded. 0% 20% 40% 60% 80% 100% 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 90 & over 80s 70s 60s Under 60 Age Profile Figure 2 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 Non-operative ASA 5 ASA 4 ASA 3 ASA 2 ASA 1 ASA Profile Figure 3 Funnell plot of crude and adjusted mortality rates within 30 days (2014) Figure 1 0% 20% 40% 60% 80% 100% 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 THR Other Int. fix. IM nail Hemi. DHS Types of operations Figure 4 0% 20% 40% 60% 80% 100% 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 THR Other Int. fix. IM nail Hemi. DHS Treatment of displaced I/C fractures Figure 5 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 Cons. Other operations IM nail DHS Treatment of ‘simple’ E/C fractures Figure 6 Other NICE compliance Other NICE recommendations RVH Surgery on day of/day after admission 45% within 36 hr in 2015 Planned trauma list Standard Aim to FWB immediately Standard Stem of proven design Standard Cement in arthroplasty Standard Anterolat. approach Standard Figure 8 0% 20% 40% 60% 80% 100% 2000 2002 2004 2006 2008 2010 2012 2014 Over 36 hr Within 36 hr Operations within 36 hours Figure 10 0.0 10.0 20.0 30.0 40.0 50.0 60.0 70.0 80.0 90.0 100.0 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 Percentage mortality ASA 1 ASA 2 ASA 3 ASA 4 Non-operative 30 Day mortality rate & ASA Figure 12 0.0 5.0 10.0 15.0 20.0 ASA 1 ASA 2 ASA 3 ASA 4 ASA 5 Overall 2014 Recent & overall 30-day mortality risk of operated patients Percentage mortality 1 1 mortality Figure 13 0.0 2.0 4.0 6.0 8.0 10.0 2011 2012 2013 2014 2015 Within 36 hr Over 36 hr 30-day mortality & 36-hour delay (2011-2015) Figure 14 Hours of ortho-physician input Figure 15 Mean cumulative time to operation 0.0 2.0 4.0 6.0 8.0 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 Admission to operation Presentation to admission Figure 9 0 2 4 6 8 Time interval (days) 0.0 5.0 10.0 15.0 20.0 25.0 30.0 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 121-365 days 31-120 days </= 30 days Combined mortality rates Figure 11 1 1 2 2 3 Percentage mortality Treatment of subtrochanteric fractures 0% 20% 40% 60% 80% 100% 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 Figure 7 Cons. Other operations IM nail DHS

Upload: others

Post on 08-Aug-2020

45 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Hip fractures in the Royal Victoria Hospital, Belfast: A ... · Hip fractures in the Royal Victoria Hospital, Belfast: A 15-year experience for hip fractures from a regional trauma

Hip fractures in the Royal Victoria Hospital, Belfast: A 15-year experience for hip fractures from a regional trauma centre

Mrs Julie Craig (Orthopaedic Specialty Doctor), Mrs Sinead McDonald (Fracture Outcomes Research Database), Dr Gary Heyburn (Consultant Ortho-physician), Mr R John Barr (Consultant Orthopaedic Surgeon)

Royal Victoria Hospital, Belfast

Background•  The Royal Victoria Hospital (RVH) in Belfast received 865 –

1066 hip fracture admission per year in from 2000-2015 •  The Fracture Outcomes Research Database (FORD) was

created 16 years ago for collection of inpatient fracture data.

Low 30-Day mortality rate •  The UK National Hip Fracture Database (NHFD) identified

RVH as the sole ”‘outlier’ – with mortality below the lower 99.8% limit” [1] for hip fracture admissions in 2014 (Figure 1).

•  ‘In 2014 the crude mortality rate (4.4%) & adjusted rate (3.9%) for this unit lay well below the 7.5% average for the NHFD.’ [1]

•  Mortality rates have been independently verified by Business Services Organisation.

Aim•  The aim was to review demographic and clinical factors which may have

contributed to these low mortality rates and their gradual improvement over several years.

Results Improvements not attributable to lower ASA or ASA grades: •  Increasing mean patient age (now 60% aged 80 or over – Figure 2). •  Increasing mean ASA (now 54% ASA Grade 3 and 26% ASA 4 – Figure 3). Improvements not attributable to ‘easier operations’: •  Increasing numbers of more complex procedures such as IM nails and THR

(Figure 4). Improved compliance with evidence-based guidance has occurred (e.g. NICE guidelines [2] and AAGBI guidelines [3]) •  Cemented hemiarthoplasty is used in almost 75% of displaced intracapsular

fractures (Figure 5). •  The rate of THR for eligible patients (25%) has been close to the NHFD average. •  All arthroplasty is cemented, with routine use of the AAGBI guidelines on

reducing the risk from cemented hemiarthroplasty [3]. •  Over 75% of ‘simple’ extracapsular fractures are treated with a DHS, & the rest

with IM nails (Figure 6). •  IM nails are now used for 94% of subtrochanteric fractures (Figure 7) .

•  Good adherence to other points of NICE guidance has been routinely implemented (Figure 8).

•  Time to theatre remains an issue, with most patients waiting around two days for surgery, of which over 80% is RVH inpatient waiting time (Figure 9).

•  RVH is subject to UK Department of Health 48-hour targets. •  The Best Practice Tariff funding criteria (not available in Northern Ireland)

require surgery to occur on the day of admission or the following day. •  Considering 36 hours as more comparable this, only 26% of RVH patients

were operated on within 36 hours in 2014 (Figure 10). •  Mortality rates for the first 30 days, and for 1 year, are low and have been

gradually improving (Figure 11).

•  The highest mortality rate occurs in the very small number of patients (<2%) who cannot be medically optimised to allow surgery (shown in orange in Figure 12 ).

•  However, mortality rates have been low for operated patients of all ASA grades. •  30-day mortality rates rise with ASA, but recent results have been improved in

comparison with the average since 2000 (stated as ‘overall’ in Figure 13).

•  While we are striving to improve waiting times and don’t for a moment condone delays, we have observed that patients who had to wait over 36 hours had a better 30-day survival rate than those operated on within 36 hours (Figure 14).

•  This is difficult to explain but it is probably due to our high level of ortho-physician care (Figure 15).

•  It is our view that our key strength is our multidiscliplinary team work in the best interests of each patient.

Conclusion RVH displays low 30-day mortality rates despite delays to theatre, seemingly due to: •  Rationalisation of treatment according to evidence and guidelines •  High level of ortho-physician input and, •  Multi-disciplinary co-operation.

With special thanks to the staff of the Fracture Outcomes Research Database (FORD), Mr J Elliott & Dr T Beringer

[1] Royal College of Physicians. National Hip Fracture Database mortality supplement 2016. London: RCP, 2016.

[2] National Clinical Guideline Centre. The Management of Hip Fracture in Adults. London: National Clinical Guideline Centre, 2011. www.nice.org.uk/guidance/cg124

[3] Association of Anaesthetists of Great Britain and Ireland. Safety guideline: reducing the risk from cemented hemiarthroplasty for hip fracture 2015. Anaesthesia 2015, 70, 623–626.

Method •  The Fracture Outcomes Research

Database supplied data for 15,345 hip fracture patients admitted to RVH between 2000 & 2015, including inpatient data and telephone follow-up data (for 30 days, 120 days, and 1 year excluding patients in 2015).

•  No age-groups were excluded.

0%

20%

40%

60%

80%

100%

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

90 & over80s70s60sUnder 60

Age Profile Figure 2

0%10%20%30%40%50%60%70%80%90%

100%

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

Non-operative

ASA 5

ASA 4

ASA 3

ASA 2

ASA 1

ASA Profile Figure 3

Funnell plot of crude and adjusted mortality rates within 30 days (2014) Figure 1

0%20%40%60%80%

100%

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

THROtherInt. fix.IM nailHemi.DHS

Types of operations Figure 4

0%20%40%60%80%

100%

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

THROtherInt. fix.IM nailHemi.DHS

Treatment of displaced I/C fractures Figure 5

0%10%20%30%40%50%60%70%80%90%

100%

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

Cons.Other operationsIM nailDHS

Treatment of ‘simple’ E/C fractures Figure 6

Other NICE compliance

Other NICE recommendations RVHSurgery on day of/day after admission

45% within 36 hr in 2015

Planned trauma list Standard

Aim to FWB immediately Standard

Stem of proven design Standard

Cement in arthroplasty Standard

Anterolat. approach Standard

Figure 8

0%

20%

40%

60%

80%

100%

2000

2002

2004

2006

2008

2010

2012

2014

Over 36 hrWithin 36 hr

Operations within 36 hours Figure 10

0.010.020.030.040.050.060.070.080.090.0

100.0

20

00

20

01

20

02

20

03

20

04

20

05

20

06

20

07

20

08

20

09

20

10

20

11

20

12

20

13

20

14

20

15

Perc

enta

ge

mort

alit

y

ASA 1

ASA 2

ASA 3

ASA 4

Non-operative

30 Day mortality rate & ASA Figure 12

0.0

5.0

10.0

15.0

20.0

ASA 1ASA 2ASA 3ASA 4ASA 5

Perc

enta

ge

mort

alit

y

Overall2014

Recent & overall 30-day mortality risk of operated patients

0.0

5.0

10.0

15.0

20.0

ASA 1ASA 2ASA 3ASA 4ASA 5

Perc

enta

ge

mort

alit

y

Overall2014

0.0

5.0

10.0

15.0

20.0

ASA 1ASA 2ASA 3ASA 4ASA 5

Perc

enta

ge

mort

alit

y

Overall2014

Figure 13

0.0

2.0

4.0

6.0

8.0

10.0

2011 2012 2013 2014 2015

Within 36 hrOver 36 hr

30-day mortality & 36-hour delay (2011-2015) Figure 14 Hours of ortho-physician input Figure 15

Mean cumulative time to operation

0.0

2.0

4.0

6.0

8.0

20

00

20

01

20

02

20

03

20

04

20

05

20

06

20

07

20

08

20

09

20

10

20

11

20

12

20

13

20

14

20

15Ti

me

inte

rval

(day

s)

Admission to operationPresentation to admission

0.0

2.0

4.0

6.0

8.0

20

00

20

01

20

02

20

03

20

04

20

05

20

06

20

07

20

08

20

09

20

10

20

11

20

12

20

13

20

14

20

15Ti

me

inte

rval

(day

s)

Admission to operationPresentation to admission

Figure 9

0.0

2.0

4.0

6.0

8.0

20

00

20

01

20

02

20

03

20

04

20

05

20

06

20

07

20

08

20

09

20

10

20

11

20

12

20

13

20

14

20

15Ti

me

inte

rval

(day

s)

Admission to operationPresentation to admission

0.05.0

10.015.020.025.030.0

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

Perc

enta

ge

mort

alit

y

121-365 days31-120 days</= 30 days

Combined mortality rates Figure 11

0.05.0

10.015.020.025.030.0

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

Perc

enta

ge

mort

alit

y

121-365 days31-120 days</= 30 days

Treatment of subtrochanteric fractures

0%

20%

40%

60%

80%

100%

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

Cons.Other operationsIM nailDHS

Figure 7

0%

20%

40%

60%

80%

100%

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

Cons.Other operationsIM nailDHS